[1] |
Cheng Yangyang, Li Huichao, Liu Shuo, Yang Lei, Zhang Xi, Li Qingyu, Li Haoxin, Wang Ning.
Incidence and mortality of liver cancer in Beijing, 2003—2017
[J]. Electronic Journal of Liver Tumor, 2022, 9(3): 12-16.
|
[2] |
Huang Yongchu, Cai Ruiqiang, Liu Nian, Zhou Fengsheng, Mao Xianshuang.
Analysis of postoperative pain score and risk of lung infection after liver resection based on propensity score matching
[J]. Electronic Journal of Liver Tumor, 2022, 9(3): 17-21.
|
[3] |
Wei Wei, Cui Chen, Liu Xiulian, Han Guijie, Pan Jing, Gao Yanping, Zhang Jingjing, Wang Yuan.
Investigation and influencing factors of postoperative fatigue in patients with hepatocellular carcinoma after liver transplantation
[J]. Electronic Journal of Liver Tumor, 2022, 9(3): 22-26.
|
[4] |
Zhang Junwei, Yang Xu, Wang Yunchao, Wang Yanyu, Xun Ziyu, Cheng Quancheng, Fang Jinyu, Ding Huiru, Meng Jieyi, Zhang Lei, Xu Yiyao, Sang Xinting, Zhao Haitao, Zhang Weiguang, Lu Xin.
Establishment of a rat model: associating liver partition and portal vein ligation for staged hepatectomy with hepatic fibrosis
[J]. Electronic Journal of Liver Tumor, 2022, 9(2): 1-6.
|
[5] |
Chen Qiong, Liu Yin, Liu Shuzheng, Guo Lanwei, Zheng Liyang, Xu Huifang, Wang Xiaoyang, Wang Hong, Sun Xibin, Zhang Shaokai.
Report of liver cancer incidence and mortality in 2016 and the time trends during 2010―2016 in Henan Province, China
[J]. Electronic Journal of Liver Tumor, 2022, 9(2): 7-12.
|
[6] |
Zhang Jiaoyan, Zhao Liang, Wei Wei, Ren Xuejun, Wang Chao, Sun Rui, Yu Lei, Yang Min.
Bibliometrics and visual analysis of psychological intervention for primary liver cancer patients
[J]. Electronic Journal of Liver Tumor, 2022, 9(2): 41-48.
|
[7] |
He Qiang, Zhou Lin.
To establish a comprehensive prevention and treatment system based on rapamycin for cancer recurrence after liver transplantation
[J]. Electronic Journal of Liver Tumor, 2021, 8(3): 1-7.
|
[8] |
Jiang Tao, Pan Fei, Chen Qing, Huang Jincan, He Qiang, Lang Ren.
Clinical study on individualized medication of tacrolimus after liver transplantation guided by CYP3A5 gene polymorphism for hepatocellular carcinoma
[J]. Electronic Journal of Liver Tumor, 2021, 8(3): 8-11.
|
[9] |
Xie Yan, Zhang Weiqi, Sun Jisan, Jiang Wentao.
Comparison of comprehensive therapy and local therapy of recurrence after liver transplantation in patients with hepatocellular carcinoma beyond Milan criteria
[J]. Electronic Journal of Liver Tumor, 2021, 8(3): 12-16.
|
[10] |
Lyu Shaocheng, Lang Ren.
Progress on liver transplantation in the treatment of liver metastases
[J]. Electronic Journal of Liver Tumor, 2021, 8(3): 26-29.
|
[11] |
Xiong Jun, Wan Chidan.
Immune checkpoint inhibitors in liver transplantation patients with hepatocellular carcinoma
[J]. Electronic Journal of Liver Tumor, 2021, 8(3): 30-34.
|
[12] |
Cao Yin, Wang Zhongxia, Jiang Chunping.
The prognostic value of simple inflammation-related indexes in predicting liver transplantation for hepatocellular carcinoma
[J]. Electronic Journal of Liver Tumor, 2021, 8(3): 35-40.
|
[13] |
Lin Xin, Xiao Min, Li Qiyong.
How to evaluate donors' liver volume: a review of researches
[J]. Electronic Journal of Liver Tumor, 2021, 8(3): 41-45.
|
[14] |
Zheng Yuanwen, Liu Jun.
Discussion on the whole course management of preventing recurrence of liver cancer after liver transplantation
[J]. Electronic Journal of Liver Tumor, 2021, 8(3): 46-50.
|
[15] |
Huang Xiaozhun, Wang Chunling, Huang Zhangkan, Xu Lin, Ma Teng, Yin Xin, Bi Xinyu, Che Xu.
Research progress on Pringle maneuver and half hepatic vascular exclusion in hepatectomy
[J]. Electronic Journal of Liver Tumor, 2021, 8(3): 55-58.
|